RSS

Mergers & acquisitions (M&A)

In an effort to strengthen its cancer treatment portfolio, major pharma company Eli Lilly has announced it is to acquire the biopharmaceutical company Loxo Oncology for $8 billion. Read more

News

In a major biopharmaceutical shake-up, Bristol-Myers Squibb has announced that it will acquire Celgene for $74 billion. Read more

News

Jennifer Lopez, director, solutions delivery at Maetrics discusses why heightened due diligence is needed for pharmaceutical manufacturers during mergers and acquisitions. Read more

Opinion

The Nov/Dec issue of @EPM_magazine is available for download with all the regulars and features on containment, regulatory affairs, the latest in M&A and a round-up of 2018's highlights. Read more

Latest Issue

GSK has announced it will merge its consumer healthcare business with Pfizer, in a major shake-up of the company. Read more

News

Pharmaceutical giant GSK has announced a major acquisition of the biotech company Tesaro to help bolster its oncology pipeline. Read more

News

This year will be big for Duchenne muscular dystrophy (DMD) as interest in treatments is on the rise and deal activity is increasing, reported data and analytics company, GlobalData. Read more

Analysis

According to Catalyst Corporate Finance, UK service-based pharma businesses involved in ‘smart’ areas of the market are experiencing heightened interest from domestic and international acquirers. Read more

Analysis

According to data from Catalyst Corporate Finance, the UK business of Alantra, 2017 has seen M&A and investment activity in the UK Healthcare sector remain high. Here, Justin Crowther (partner) identifies five significant deals of the year Read more

News

In a press statement from the European Commission, it has been announced that the proposed acquisition of Huber Silica by Evonik has been approved, subject to divestment of some of both companies’ activities relating to precipitated silica. Read more

News

Despite a downturn in M&A activity during the latter part of 2016, prospects are on the rise. In this article, we analyse what deals are on the table, coming to the table and those that are still in the kitchen waiting to be plated up! Read more

Opinion

Alexandre Alain, life science product manager at compliance management company EtQ writes about mergers and acquisitions in the life sciences sector. Read more

News

Capsule specialist Capsugel is acquired by major pharma player Lonza, and investment firm KKR. Read more

News

Life science mergers and acquisitions are on the rise, but risk management is crucial if M&A deals are to add genuine business value Read more

News

It seems we’re never far from a merger or acquisition in the pharmaceutical sector Read more

Opinion

PFIZERALLERGAN.jpg

Rob Wilson / Shutterstock.com

Big pharma player Pfizer has inked its long-rumoured deal to buy botox maker Allergan, in what the BBC describes as “the biggest pharmaceuticals deal in history” Read more

News

With hostile takeovers on the rise, Mike Straw, CEO of Achieve Breakthrough, looks at how both sides can adapt and succeed Read more

Opinion

Mergers & acquisitions – it’s all about collaboration, says Mike Straw, Achieve Breakthrough. He argues that deals are all about people as well as the numbers – and it’s the collaboration that will make a deal truly work. Read more

Opinion

Patheon explains the importance of mergers and acquisitions as the company strengthens its position in the sector. Read more

Opinion

China-based biotechnology company 3SBio has acquired the entire share capital of Italian group Sirton Pharmaceuticals. Read more

News